Derivatives and Hedging Activities (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
| Derivative Instruments and Hedging Activities Disclosure [Abstract] |
|
| Fair Value of Derivatives on a Gross Basis |
The tables below present the gross fair value and the notional amounts of derivative contracts by major product type, the amounts of counterparty and cash collateral netting in the consolidated balance sheets, as well as cash and securities collateral posted and received under enforceable credit support agreements that do not meet the criteria for netting under U.S. GAAP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
As of December 2020 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
Not accounted for as hedges |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 665 |
|
|
|
$ 660 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,832 |
|
|
|
16,809 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
337,998 |
|
|
|
304,370 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
357,495 |
|
|
|
321,839 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,137 |
|
|
|
4,517 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,418 |
|
|
|
11,551 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,555 |
|
|
|
16,068 |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133 |
|
|
|
22 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
401 |
|
|
|
631 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101,830 |
|
|
|
102,676 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102,364 |
|
|
|
103,329 |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,476 |
|
|
|
4,177 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
195 |
|
|
|
187 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,320 |
|
|
|
13,691 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,991 |
|
|
|
18,055 |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,006 |
|
|
|
31,944 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
– |
|
|
|
– |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,867 |
|
|
|
49,072 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76,873 |
|
|
|
81,016 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
567,278 |
|
|
|
540,307 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
– |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,346 |
|
|
|
– |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,347 |
|
|
|
– |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
– |
|
|
|
87 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
372 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
459 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,351 |
|
|
|
459 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 568,629 |
|
|
|
$ 540,766 |
|
| Offset in the consolidated balance sheets |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (29,549 |
) |
|
|
$ (29,549 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(21,315 |
) |
|
|
(21,315 |
) |
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(372,142 |
) |
|
|
(372,142 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(423,006 |
) |
|
|
(423,006 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,926 |
) |
|
|
(720 |
) |
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(74,116 |
) |
|
|
(58,449 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(76,042 |
) |
|
|
(59,169 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$(499,048 |
) |
|
|
$(482,175 |
) |
Included in the consolidated balance sheets |
|
| Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,731 |
|
|
|
$ 7,254 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
325 |
|
|
|
196 |
|
| Bilateral OTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64,525 |
|
|
|
51,141 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 69,581 |
|
|
|
$ 58,591 |
|
| Not offset in the consolidated balance sheets |
|
| Cash collateral |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (979 |
) |
|
|
$ (2,427 |
) |
| Securities collateral |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17,297 |
) |
|
|
(9,943 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 51,305 |
|
|
|
$ 46,221 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Notional Amounts as of December |
|
| |
|
|
|
|
|
|
|
|
|
2020 |
|
Not accounted for as hedges |
|
|
|
|
|
|
|
|
| Exchange-traded |
|
|
|
|
|
|
$ 3,722,558 |
|
| |
|
|
|
|
|
|
13,789,571 |
|
| Bilateral OTC |
|
|
|
|
|
|
11,076,460 |
|
| |
|
|
|
|
|
|
28,588,589 |
|
| |
|
|
|
|
|
|
515,197 |
|
| Bilateral OTC |
|
|
|
|
|
|
558,813 |
|
| |
|
|
|
|
|
|
1,074,010 |
|
| Exchange-traded |
|
|
|
|
|
|
7,413 |
|
| |
|
|
|
|
|
|
157,687 |
|
| Bilateral OTC |
|
|
|
|
|
|
6,041,663 |
|
| |
|
|
|
|
|
|
6,206,763 |
|
| Exchange-traded |
|
|
|
|
|
|
242,193 |
|
| |
|
|
|
|
|
|
2,315 |
|
| Bilateral OTC |
|
|
|
|
|
|
206,253 |
|
| |
|
|
|
|
|
|
450,761 |
|
| Exchange-traded |
|
|
|
|
|
|
948,937 |
|
| |
|
|
|
|
|
|
– |
|
| Bilateral OTC |
|
|
|
|
|
|
1,126,572 |
|
| |
|
|
|
|
|
|
2,075,509 |
|
| |
|
|
|
|
|
|
38,395,632 |
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
182,311 |
|
| Bilateral OTC |
|
|
|
|
|
|
6,641 |
|
| |
|
|
|
|
|
|
188,952 |
|
| |
|
|
|
|
|
|
1,767 |
|
| Bilateral OTC |
|
|
|
|
|
|
14,055 |
|
| |
|
|
|
|
|
|
15,822 |
|
| Exchange-traded |
|
|
|
|
|
|
– |
|
| |
|
|
|
|
|
|
– |
|
| |
|
|
|
|
|
|
204,774 |
|
| |
|
|
|
|
|
|
$38,600,406 |
| In the tables above:
| • |
|
Gross fair values exclude the effects of both counterparty netting and collateral, and therefore are not representative of the firm’s exposure. |
| • |
|
Where the firm has received or posted collateral under credit support agreements, but has not yet determined such agreements are enforceable, the related collateral has not been netted. |
| • |
|
Notional amounts, which represent the sum of gross long and short derivative contracts, provide an indication of the volume of the firm’s derivative activity and do not represent anticipated losses. |
| • |
|
Total gross fair value of derivatives included derivative assets of $17.48 billion as of December 2021 and $20.60 billion as of December 2020, and derivative liabilities of $17.29 billion as of December 2021 and $22.98 billion as of December 2020, which are not subject to an enforceable netting agreement or are subject to a netting agreement that the firm has not yet determined to be enforceable. |
|
| Fair Value of Derivatives by Level |
The table below presents derivatives on a gross basis by level and product type, as well as the impact of netting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Currencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commodities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Counterparty netting in levels |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Currencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commodities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Counterparty netting in levels |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
$ 297 |
|
|
|
$357,568 |
|
|
|
$ 977 |
|
|
|
$358,842 |
|
| Credit |
|
|
– |
|
|
|
13,104 |
|
|
|
3,451 |
|
|
|
16,555 |
|
| Currencies |
|
|
– |
|
|
|
102,221 |
|
|
|
147 |
|
|
|
102,368 |
|
| Commodities |
|
|
– |
|
|
|
13,285 |
|
|
|
706 |
|
|
|
13,991 |
|
| Equities |
|
|
75 |
|
|
|
75,054 |
|
|
|
1,744 |
|
|
|
76,873 |
|
| Gross fair value |
|
|
372 |
|
|
|
561,232 |
|
|
|
7,025 |
|
|
|
568,629 |
|
| Counterparty netting in levels |
|
|
(135 |
) |
|
|
(420,685 |
) |
|
|
(1,058 |
) |
|
|
(421,878 |
) |
| Subtotal |
|
|
$ 237 |
|
|
|
$140,547 |
|
|
|
$5,967 |
|
|
|
$146,751 |
|
| Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,128 |
) |
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(76,042 |
) |
| Net fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 69,581 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
$(229 |
) |
|
|
$ (320,900 |
) |
|
|
$ (710 |
) |
|
|
$ (321,839 |
) |
| Credit |
|
|
– |
|
|
|
(14,395 |
) |
|
|
(1,673 |
) |
|
|
(16,068 |
) |
| Currencies |
|
|
– |
|
|
|
(103,303 |
) |
|
|
(485 |
) |
|
|
(103,788 |
) |
| Commodities |
|
|
– |
|
|
|
(17,649 |
) |
|
|
(406 |
) |
|
|
(18,055 |
) |
| Equities |
|
|
(318 |
) |
|
|
(78,122 |
) |
|
|
(2,576 |
) |
|
|
(81,016 |
) |
| Gross fair value |
|
|
(547 |
) |
|
|
(534,369 |
) |
|
|
(5,850 |
) |
|
|
(540,766 |
) |
| Counterparty netting in levels |
|
|
135 |
|
|
|
420,685 |
|
|
|
1,058 |
|
|
|
421,878 |
|
| Subtotal |
|
|
$(412 |
) |
|
|
$ (113,684 |
) |
|
|
$ (4,792 |
) |
|
|
$ (118,888 |
) |
| Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,128 |
|
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,169 |
|
| Net fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (58,591 |
) |
|
| Fair Value, Derivatives, Measurement Inputs, Disclosure |
The table below presents the amount of level 3 derivative assets (liabilities), and ranges, averages and medians of significant unobservable inputs used to value level 3 derivatives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
As of December 2020 |
|
| |
|
|
|
|
|
$ in millions, except inputs |
|
|
|
|
|
|
|
|
|
|
|
|
Amount or Range |
|
|
|
Average/ Median |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
$267 |
|
|
|
|
|
| Correlation |
|
|
|
|
|
|
|
|
|
|
|
|
(8)% to 81% |
|
|
|
56%/60% |
|
| Volatility (bps) |
|
|
|
|
|
|
|
|
|
|
|
|
31 to 150 |
|
|
|
65/53 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
$1,778 |
|
|
|
|
|
| Credit spreads (bps) |
|
|
|
|
|
|
|
|
|
|
|
|
2 to 699 |
|
|
|
109/74 |
|
| Upfront credit points |
|
|
|
|
|
|
|
|
|
|
|
|
7 to 90 |
|
|
|
40/30 |
|
| Recovery rates |
|
|
|
|
|
|
|
|
|
|
|
|
25% to 90% |
|
|
|
46%/40% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
$(338) |
|
|
|
|
|
| Correlation |
|
|
|
|
|
|
|
|
|
|
|
|
20% to 70% |
|
|
|
39%/41% |
|
| Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
18% to 18% |
|
|
|
18%/18% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
$300 |
|
|
|
|
|
| Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
15% to 87% |
|
|
|
32%/30% |
|
| Natural gas spread |
|
|
|
|
|
|
|
|
|
|
|
|
$(1.00) to $2.13 |
|
|
|
$(0.13)/ $(0.09) |
|
| Oil spread |
|
|
|
|
|
|
|
|
|
|
|
|
$8.30 to $11.20 |
|
|
|
$9.73/ $9.55 |
|
| Electricity price |
|
|
|
|
|
|
|
|
|
|
|
|
N/A
|
|
|
|
N/A
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
$(832) |
|
|
|
|
|
| Correlation |
|
|
|
|
|
|
|
|
|
|
|
|
(70)% to 100% |
|
|
|
52%/55% |
|
| Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
3% to 129% |
|
|
|
14%/7% |
|
|
| Fair Value of Derivatives, Level 3 Rollforward |
The table below presents a summary of the changes in fair value for level 3 derivatives.
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December |
|
| |
|
|
|
|
|
|
|
|
|
2020 |
|
Total level 3 derivatives, net |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$ 25 |
|
| Net realized gains/(losses) |
|
|
|
|
|
|
226 |
|
| Net unrealized gains/(losses) |
|
|
|
|
|
|
612 |
|
| Purchases |
|
|
|
|
|
|
319 |
|
| Sales |
|
|
|
|
|
|
(724 |
) |
| Settlements |
|
|
|
|
|
|
750 |
|
| Transfers into level 3 |
|
|
|
|
|
|
(40 |
) |
| Transfers out of level 3 |
|
|
|
|
|
|
7 |
|
| |
|
|
|
|
|
|
$1,175 |
| The table below presents information, by product type, for derivatives included in the summary table above.
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December |
|
| |
|
|
|
|
|
|
|
|
|
2020 |
|
| |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$ 89 |
|
| Net realized gains/(losses) |
|
|
|
|
|
|
12 |
|
| Net unrealized gains/(losses) |
|
|
|
|
|
|
226 |
|
| Purchases |
|
|
|
|
|
|
12 |
|
| Sales |
|
|
|
|
|
|
(28 |
) |
| Settlements |
|
|
|
|
|
|
(34 |
) |
| Transfers into level 3 |
|
|
|
|
|
|
(13 |
) |
| Transfers out of level 3 |
|
|
|
|
|
|
3 |
|
| |
|
|
|
|
|
|
$ 267 |
|
| |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$ 1,877 |
|
| Net realized gains/(losses) |
|
|
|
|
|
|
28 |
|
| Net unrealized gains/(losses) |
|
|
|
|
|
|
110 |
|
| Purchases |
|
|
|
|
|
|
39 |
|
| Sales |
|
|
|
|
|
|
(50 |
) |
| Settlements |
|
|
|
|
|
|
(229 |
) |
| Transfers into level 3 |
|
|
|
|
|
|
47 |
|
| Transfers out of level 3 |
|
|
|
|
|
|
(44 |
) |
| |
|
|
|
|
|
|
$ 1,778 |
|
| |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$ (211 |
) |
| Net realized gains/(losses) |
|
|
|
|
|
|
(8 |
) |
| Net unrealized gains/(losses) |
|
|
|
|
|
|
(210 |
) |
| Purchases |
|
|
|
|
|
|
1 |
|
| Sales |
|
|
|
|
|
|
(20 |
) |
| Settlements |
|
|
|
|
|
|
117 |
|
| Transfers into level 3 |
|
|
|
|
|
|
(2 |
) |
| Transfers out of level 3 |
|
|
|
|
|
|
(5 |
) |
| |
|
|
|
|
|
|
$ (338 |
) |
| |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$ 247 |
|
| Net realized gains/(losses) |
|
|
|
|
|
|
(12 |
) |
| Net unrealized gains/(losses) |
|
|
|
|
|
|
159 |
|
| Purchases |
|
|
|
|
|
|
37 |
|
| Sales |
|
|
|
|
|
|
(22 |
) |
| Settlements |
|
|
|
|
|
|
(60 |
) |
| Transfers into level 3 |
|
|
|
|
|
|
(27 |
) |
| Transfers out of level 3 |
|
|
|
|
|
|
(22 |
) |
| |
|
|
|
|
|
|
$ 300 |
|
| |
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
|
|
|
|
$(1,977 |
) |
| Net realized gains/(losses) |
|
|
|
|
|
|
206 |
|
| Net unrealized gains/(losses) |
|
|
|
|
|
|
327 |
|
| Purchases |
|
|
|
|
|
|
230 |
|
| Sales |
|
|
|
|
|
|
(604 |
) |
| Settlements |
|
|
|
|
|
|
956 |
|
| Transfers into level 3 |
|
|
|
|
|
|
(45 |
) |
| Transfers out of level 3 |
|
|
|
|
|
|
75 |
|
| |
|
|
|
|
|
|
$ (832 |
) |
|
| OTC Derivatives by Product Type and Tenor |
The table below presents OTC derivative assets and liabilities by tenor and major product type.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 1 Year |
|
|
|
1 - 5 Years |
|
|
|
Greater than 5 Years |
|
|
|
Total |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Currencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commodities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Counterparty netting in tenors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total OTC derivative assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Currencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commodities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Counterparty netting in tenors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total OTC derivative liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
$ 8,913 |
|
|
|
$20,145 |
|
|
|
$74,893 |
|
|
|
$103,951 |
|
| Credit |
|
|
822 |
|
|
|
3,270 |
|
|
|
3,302 |
|
|
|
7,394 |
|
| Currencies |
|
|
13,887 |
|
|
|
7,400 |
|
|
|
9,303 |
|
|
|
30,590 |
|
| Commodities |
|
|
2,998 |
|
|
|
1,466 |
|
|
|
488 |
|
|
|
4,952 |
|
| Equities |
|
|
12,182 |
|
|
|
12,590 |
|
|
|
1,807 |
|
|
|
26,579 |
|
| Counterparty netting in tenors |
|
|
(3,963 |
) |
|
|
(4,458 |
) |
|
|
(3,182 |
) |
|
|
(11,603 |
) |
| Subtotal |
|
|
$34,839 |
|
|
|
$40,413 |
|
|
|
$86,611 |
|
|
|
$161,863 |
|
| Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
(20,971 |
) |
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(76,042 |
) |
| Total OTC derivative assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 64,850 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rates |
|
|
$ 5,687 |
|
|
|
$11,967 |
|
|
|
$49,301 |
|
|
|
$ 66,955 |
|
| Credit |
|
|
1,268 |
|
|
|
3,462 |
|
|
|
2,177 |
|
|
|
6,907 |
|
| Currencies |
|
|
18,770 |
|
|
|
7,575 |
|
|
|
5,775 |
|
|
|
32,120 |
|
| Commodities |
|
|
3,455 |
|
|
|
1,545 |
|
|
|
4,315 |
|
|
|
9,315 |
|
| Equities |
|
|
9,702 |
|
|
|
14,095 |
|
|
|
3,986 |
|
|
|
27,783 |
|
| Counterparty netting in tenors |
|
|
(3,963 |
) |
|
|
(4,458 |
) |
|
|
(3,182 |
) |
|
|
(11,603 |
) |
| Subtotal |
|
|
$34,919 |
|
|
|
$34,186 |
|
|
|
$62,372 |
|
|
|
$131,477 |
|
| Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
(20,971 |
) |
| Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(59,169 |
) |
| Total OTC derivative liabilities |
|
|
|
|
|
|
|
|
|
|
|
$ 51,337 |
|
|
| Credit Derivatives |
The table below presents information about credit derivatives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Credit Spread on Underlier (basis points) |
|
| |
|
|
|
|
|
|
|
|
0 - 250 |
|
|
|
251 - 500 |
|
|
|
501 - 1,000 |
|
|
|
Greater than 1,000 |
|
|
|
Total |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Payout/Notional Amount of Written Credit Derivatives by Tenor |
|
| Less than 1 year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 - 5 years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Greater than 5 years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum Payout/Notional Amount of Purchased Credit Derivatives |
|
| Offsetting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value of Written Credit Derivatives |
|
| Asset |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Payout/Notional Amount of Written Credit Derivatives by Tenor |
|
| Less than 1 year |
|
|
$ 96,049 |
|
|
|
$ 5,826 |
|
|
|
$ 450 |
|
|
|
$2,403 |
|
|
|
$104,728 |
|
| 1 - 5 years |
|
|
331,145 |
|
|
|
17,913 |
|
|
|
8,801 |
|
|
|
4,932 |
|
|
|
362,791 |
|
| Greater than 5 years |
|
|
44,132 |
|
|
|
3,839 |
|
|
|
272 |
|
|
|
88 |
|
|
|
48,331 |
|
| Total |
|
|
$471,326 |
|
|
|
$27,578 |
|
|
|
$ 9,523 |
|
|
|
$7,423 |
|
|
|
$515,850 |
|
| Maximum Payout/Notional Amount of Purchased Credit Derivatives |
|
| Offsetting |
|
|
$407,315 |
|
|
|
$19,822 |
|
|
|
$ 8,679 |
|
|
|
$7,091 |
|
|
|
$442,907 |
|
| Other |
|
|
$103,604 |
|
|
|
$ 7,272 |
|
|
|
$ 3,619 |
|
|
|
$ 776 |
|
|
|
$115,271 |
|
Fair Value of Written Credit Derivatives |
|
| Asset |
|
|
$ 10,302 |
|
|
|
$ 638 |
|
|
|
$ 256 |
|
|
|
$ 118 |
|
|
|
$ 11,314 |
|
| Liability |
|
|
1,112 |
|
|
|
1,119 |
|
|
|
387 |
|
|
|
2,001 |
|
|
|
4,619 |
|
| Net asset/(liability) |
|
|
$ 9,190 |
|
|
|
$ (481 |
) |
|
|
$ (131 |
) |
|
|
$ (1,883 |
) |
|
|
$ 6,695 |
|
|
| Summary of information about CVA and FVA |
The table below presents information about CVA and FVA.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December |
|
| |
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
2019 |
|
| CVA, net of hedges |
|
|
|
|
|
|
$(143 |
) |
|
|
$(289 |
) |
| FVA, net of hedges |
|
|
|
|
|
|
173 |
|
|
|
485 |
|
| |
|
|
|
|
|
|
$ 30 |
|
|
|
$ 196 |
|
|
| Bifurcated Embedded Derivatives |
The table below presents the fair value and the notional amount of derivatives that have been bifurcated from their related borrowings.
|
|
|
|
|
|
|
|
|
|
|
| |
|
As of December |
|
| |
|
|
|
|
|
|
|
|
|
2020 |
|
| Fair value of assets |
|
|
|
|
|
|
$ 1,450 |
|
| Fair value of liabilities |
|
|
|
|
|
|
(1,220 |
) |
| |
|
|
|
|
|
|
$ 230 |
|
| |
|
|
|
|
|
|
$12,548 |
|
|
| Derivatives with Credit-Related Contingent Features |
The table below presents information about net derivative liabilities under bilateral agreements (excluding collateral posted), the fair value of collateral posted and additional collateral or termination payments that could have been called by counterparties in the event of a one- or two-notch downgrade in the firm’s credit ratings.
|
|
|
|
|
|
|
|
|
|
|
| |
|
As of December |
|
| |
|
|
|
|
|
|
|
|
|
2020 |
|
| Net derivative liabilities under bilateral agreements |
|
|
|
|
|
|
$43,368 |
|
| Collateral posted |
|
|
|
|
|
|
$35,296 |
|
| Additional collateral or termination payments: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
$ 481 |
|
| |
|
|
|
|
|
|
$ 1,388 |
|
|
| Gain (Loss) from Interest Rate Hedges and Related Hedged Borrowings and Deposits |
The table below presents the gains/(losses) from interest rate derivatives accounted for as hedges and the related hedged borrowings and deposits, and total interest expense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December |
|
| |
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
2019 |
|
| Interest rate hedges |
|
|
|
|
|
|
$ 3,862 |
|
|
|
$ 3,196 |
|
| Hedged borrowings and deposits |
|
|
|
|
|
|
$(4,557 |
) |
|
|
$ (3,657 |
) |
| Interest expense |
|
|
|
|
|
|
$ 8,938 |
|
|
|
$17,376 |
|
|
| Summary of Carrying Amount of Hedged Items |
The table below presents the carrying value of deposits and unsecured borrowings that are designated in a hedging relationship and the related cumulative hedging adjustment (increase/(decrease)) from current and prior hedging relationships included in such carrying values.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value |
|
|
|
Cumulative Hedging Adjustment |
|
| |
|
|
|
|
|
|
|
|
| Deposits |
|
|
|
|
|
|
|
|
| Unsecured short-term borrowings |
|
|
|
|
|
|
|
|
| Unsecured long-term borrowings |
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
| Deposits |
|
|
$ 17,303 |
|
|
|
$ 649 |
|
| Unsecured short-term borrowings |
|
|
$ 5,976 |
|
|
|
$ 53 |
|
| Unsecured long-term borrowings |
|
|
$115,242 |
|
|
|
$11,624 |
| The table below presents the gains/(losses) from net investment hedging.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December |
|
| |
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
2019 |
|
| Hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency forward contract |
|
|
|
|
|
|
$(126 |
) |
|
|
$ 6 |
|
| Foreign currency-denominated debt |
|
|
|
|
|
|
$(297 |
) |
|
|
$(19 |
) |
|